lansoprazole has been researched along with Regurgitation, Gastric in 11 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Regurgitation, Gastric: GASTROESOPHAGEAL REFLUX wherein the retrograde flow passes through the UPPER ESOPHAGEAL SPHINCTER
| Excerpt | Relevance | Reference |
|---|---|---|
| " Laryngopharyngeal reflux patients underwent three-month lansoprazole treatment." | 3.83 | New inflammatory parameters in laryngopharyngeal reflux. ( Akmansu, ŞH; Arslan, H; Çandar, T; Kocatürk, S; Kuran, S, 2016) |
| "Persistent throat symptoms and Extra Oesophageal Reflux (EOR) are among the commonest reasons for attendance at a secondary care throat or voice clinic." | 2.82 | TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. ( Carding, P; Fouweather, T; Lecouturier, J; O'Hara, J; Stocken, D; Watson, G; Wilson, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YC | 3 |
| Jung, AR | 1 |
| Kwon, OE | 1 |
| Kang, JW | 1 |
| Huh, JH | 1 |
| Eun, YG | 3 |
| Giral, A | 1 |
| Kurt, R | 1 |
| Yeğin, EG | 1 |
| Yeğin, K | 1 |
| Lee, JS | 2 |
| Kim, SW | 2 |
| Kwon, KH | 2 |
| Watson, G | 1 |
| O'Hara, J | 1 |
| Carding, P | 1 |
| Lecouturier, J | 1 |
| Stocken, D | 1 |
| Fouweather, T | 1 |
| Wilson, J | 1 |
| Arslan, H | 1 |
| Çandar, T | 1 |
| Kuran, S | 1 |
| Akmansu, ŞH | 1 |
| Kocatürk, S | 1 |
| Zeleník, K | 1 |
| Matoušek, P | 1 |
| Urban, O | 1 |
| Schwarz, P | 1 |
| Stárek, I | 1 |
| Komínek, P | 1 |
| Juul-Hansen, P | 1 |
| Rydning, A | 1 |
| Naiboglu, B | 1 |
| Durmus, R | 1 |
| Tek, A | 1 |
| Toros, SZ | 1 |
| Egeli, E | 1 |
| Garza, JM | 1 |
| Nylund, CM | 1 |
| Kaul, A | 1 |
| Chun, BJ | 1 |
| Lee, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion[NCT02183974] | 44 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
| Comparison of Three Methods Used in the Diagnosis of Extraesophageal Reflux in Children With Chronic Otitis Media With Effusion[NCT02183961] | 24 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for lansoprazole and Regurgitation, Gastric
| Article | Year |
|---|---|
Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
Topics: Adult; Aged; Aged, 80 and over; Deglutition; Female; Follow-Up Studies; Health Surveys; Humans; Lans | 2014 |
TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
Topics: Clinical Protocols; Feasibility Studies; Gastroesophageal Reflux; Humans; Lansoprazole; Laryngophary | 2016 |
Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Chromogranins; Esophagitis; | 2011 |
The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzamides; Benzyl Compound | 2013 |
7 other studies available for lansoprazole and Regurgitation, Gastric
| Article | Year |
|---|---|
The effect of baclofen combined with a proton pump inhibitor in patients with refractory laryngopharyngeal reflux: A prospective, open-label study in thirty-two patients.
Topics: Adult; Aged; Baclofen; Drug Therapy, Combination; Esophageal pH Monitoring; Female; Humans; Lansopra | 2019 |
Signal detection theory approach to gastroesophageal reflux disease: a new method for symptom analysis of impedance-pH data.
Topics: Adult; Electric Impedance; Esophageal pH Monitoring; Esophageal Sphincter, Lower; Female; Gastroesop | 2014 |
Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cohort Studies; Dose- | 2013 |
New inflammatory parameters in laryngopharyngeal reflux.
Topics: Adult; Biomarkers; Case-Control Studies; Humans; Inflammation; Lansoprazole; Laryngopharyngeal Reflu | 2016 |
Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Body Mass Index; Cohort Studies; Female | 2010 |
Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Body Mass Index; Cohort Studies; Female | 2010 |
Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Body Mass Index; Cohort Studies; Female | 2010 |
Globus pharyngeus and extraesophageal reflux: simultaneous pH <4.0 and pH <5.0 analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Body Mass Index; Cohort Studies; Female | 2010 |
Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Dose-Response Relationship, Drug; Female; Gastroesop | 2011 |
Time to stop blaming gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cough; Diagnosis, Differential; Electric Impedance; Enzyme | 2011 |